Short Interest in Jin Medical International Ltd. (NASDAQ:ZJYL) Decreases By 58.6%

Jin Medical International Ltd. (NASDAQ:ZJYLGet Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totaling 7,826 shares, a decrease of 58.6% from the June 15th total of 18,894 shares. Based on an average daily volume of 22,603 shares, the short-interest ratio is presently 0.3 days. Currently, 0.1% of the company’s stock are sold short.

Jin Medical International Stock Up 2.6%

ZJYL stock traded up $0.05 during trading on Wednesday, reaching $2.01. The company had a trading volume of 2,774 shares, compared to its average volume of 153,050. The firm has a 50-day simple moving average of $2.30 and a 200-day simple moving average of $2.65. Jin Medical International has a twelve month low of $1.64 and a twelve month high of $17.18.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded Jin Medical International from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, June 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Read Our Latest Stock Report on Jin Medical International

About Jin Medical International

(Get Free Report)

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Featured Stories

Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.